Carbonic anhydrase inhibitors. Inhibition of the fungal β-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids

被引:45
|
作者
Innocenti, Alessio [1 ]
Winum, Jean-Yves [2 ]
Hall, Rebecca A. [3 ]
Muehlschlegel, Fritz A. [3 ]
Scozzafava, Andrea [2 ]
Supuran, Claudiu T. [1 ]
机构
[1] Univ Florence, Lab Chim Bioinorgan, I-50019 Florence, Italy
[2] Ecole Natl Super Chim Montpellier, IBMM, CNRS UM1 UM2, UMR 5247, F-34296 Montpellier, France
[3] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England
基金
英国生物技术与生命科学研究理事会;
关键词
Carbonic anhydrase; Beta-class enzyme; Cryptococcus neoformans; Candida albicans; Can2; Nce103; Boronic acid; ISOZYME-IV; CLASS ENZYMES; ANIONS; PROTEASOME; VIRULENCE; POTENT; CO2; IX; CARBOXYLATES; BORTEZOMIB;
D O I
10.1016/j.bmcl.2009.03.147
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibition of the beta-carbonic anhydrases (CAs, EC 4.2.1.1) from the pathogenic fungi Cryptococcus neoformans (Can2) and Candida albicans (Nce103) with a series of aromatic, arylalkenyl- and arylalkylboronic acids was investigated. Aromatic, 4-phenylsubstituted- and 2-naphthylboronic acids were the best Can2 inhibitors, with inhibition constants in the range of 8.5-11.5 mu M, whereas arylalkenyl and aryalkylboronic acids showed K(I)s in the range of 428-3040 mu M. Nce103 showed a similar inhibition pro. le, with the 4-phenylsubstituted- and 2-naphthylboronic acids possessing K(I)s in the range of 7.8-42.3 mu M, whereas the arylalkenyl and aryalkylboronic acids were weaker inhibitors (K(I)s of 412-5210 mu M). The host human enzymes CAI and II were also effectively inhibited by these boronic acids. The B(OH)(2) moiety is thus a new zinc-binding group for designing effective inhibitors of the alpha- and beta-CAs. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2642 / 2645
页数:4
相关论文
共 50 条
  • [41] Carbonic Anhydrase Inhibitors: Inhibition of Human Erythrocyte Isozymes I and II with a Series of Phenolic Acids
    Sarikaya, S. Beyza Oeztuerk
    Gulcin, Ilhami
    Supuran, Claudiu T.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 75 (05) : 515 - 520
  • [42] Crystal structure of carbonic anhydrase CaNce103p from the pathogenic yeast Candida albicans
    Dostal, Jiri
    Brynda, Jiri
    Blaha, Jan
    Machacek, Stanislav
    Heidingsfeld, Olga
    Pichova, Iva
    BMC STRUCTURAL BIOLOGY, 2018, 18
  • [43] Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design
    Lehtonen, JM
    Parkkila, S
    Vullo, D
    Casini, A
    Scozzafava, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (14) : 3757 - 3762
  • [44] Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V and IX with complex fluorides, chlorides and cyanides
    Innocenti, A
    Antel, J
    Wurl, M
    Vullo, D
    Firnges, MA
    Scozzafava, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) : 1909 - 1913
  • [45] Carbonic anhydrase inhibitors.: Inhibition of the transmembrane isozyme XII with sulfonamides -: a new target for the design of antitumor and antiglaucoma drugs?
    Vullo, D
    Innocenti, A
    Nishimori, I
    Pastorek, J
    Scozzafava, A
    Pastoreková, S
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (04) : 963 - 969
  • [46] Carbonic anhydrase inhibitors:: DNA cloning and inhibition studies of the α-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs
    Nishimori, I
    Minakuchi, T
    Morimoto, K
    Sano, S
    Onishi, S
    Takeuchi, H
    Vullo, D
    Scozzafava, A
    Supuran, CT
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (06) : 2117 - 2126
  • [47] Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions
    Innocenti, Alessio
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (07) : 1855 - 1857
  • [48] Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with anions
    Vullo, D
    Franchi, M
    Gallori, E
    Pastorek, J
    Scozzafava, A
    Pastorekova, S
    Supuran, CT
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2003, 18 (05) : 403 - 406
  • [49] Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate
    Innocenti, Alessio
    Scozzafava, Andrea
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (05) : 1548 - 1550
  • [50] Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors
    Nishimori, Isao
    Minakuchi, Tomoko
    Onishi, Saburo
    Vullo, Daniela
    Scozzafava, Andrea
    Supuran, Claudiu T.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (02) : 381 - 388